Table 3.
PRO measure | Validity indicator |
|
---|---|---|
VAS | Productivity | |
FACT-B trial outcome index | 0.641 P < .001 n= 73 |
0.613 P < .001 n = 755 |
PROMIS fatigue | −0.523 P < .001 n = 727 |
— |
PROMIS anxiety | −0.408 P < .001 n = 734 |
— |
PROMIS ability to participate in social roles and activities | 0.593 P < .001 n = 730 |
— |
PRO-CTCAE severity of shortness of breath at its worst | — | −0.191 P < .001 n = 751 |
PRO-CTCAE shortness of breath interferes with usual activities | — | −0.260 P < .001 n = 727 |
PRO-CTCAE frequency of chest pain, chest tightness, or angina | — | −0.199 P < .001 n = 751 |
PRO-CTCAE severity of chest pain, chest tightness, or angina at its worst | — | −0.210 P < .001 n = 724 |
PRO-CTCAE chest pain, chest tightness, or angina interferes with usual activities | — | −0.230 P < .001 n = 725 |
—: no associations between variables were expected or evaluated. For FACT-B, higher scores represent better health-related quality of life. For PROMIS, higher scores represent more of the outcome, eg, more fatigue, more anxiety, better ability. VAS ranges from 0 (worst imaginable health) to 100 (best imaginable health). Productivity represents a single item that assesses the extent that a patient was able to resume normal activities.
Abbreviations: FACT-B = Functional Assessment of Cancer Therapy-Breast; PRO = patient-reported outcome; PRO-CTCAE = Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events; PROMIS = Patient-Reported Outcomes Measurement Information System; VAS = Visual Analog Scale from the EQ-5D.